Genenta Science Files 6-K Report
Ticker: GNTA · Form: 6-K · Filed: Oct 10, 2025 · CIK: 1838716
| Field | Detail |
|---|---|
| Company | Genenta Science S.P.A. (GNTA) |
| Form Type | 6-K |
| Filed Date | Oct 10, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, biotech
Related Tickers: GNTA
TL;DR
Genenta Science (GNTA) filed a 6-K on Oct 10, 2025, updating its status for Q2 2025.
AI Summary
Genenta Science S.p.A. filed a Form 6-K on October 10, 2025, reporting information for the period ending June 30, 2025. The filing is incorporated by reference into the company's Form F-3 registration statement (File No. 333-270046). The company is a foreign private issuer based in Milan, Italy, and operates in the biological products sector.
Why It Matters
This filing provides updated information for investors and regulators regarding Genenta Science's financial and operational status as of mid-2025.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that provides an update and does not appear to contain significant new material events or financial distress.
Key Numbers
- 20250630 — Period of Report (The financial and operational data pertains to this date.)
- 20251010 — Filing Date (The date the report was submitted to the SEC.)
Key Players & Entities
- Genenta Science S.p.A. (company) — Filer of the report
- 001-41115 (company) — SEC File Number
- 333-270046 (company) — Form F-3 Registration Statement File Number
- Milan, Italy (location) — Company's principal executive office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose to any" member of the public.".
What period does this 6-K filing cover?
This Form 6-K reports information for the period ending June 30, 2025.
Where is Genenta Science S.p.A. located?
Genenta Science S.p.A.'s principal executive office is located at Via Olgettina No. 58, 20132 Milan, Italy.
Is Genenta Science S.p.A. required to file annual reports on Form 20-F?
Yes, the registrant indicates it files annual reports under cover of Form 20-F.
What other SEC filing is referenced in this 6-K?
This Form 6-K is incorporated by reference into the registrant's registration statement on Form F-3 (File No. 333-270046).
Filing Stats: 411 words · 2 min read · ~1 pages · Grade level 9.8 · Accepted 2025-10-10 16:06:00
Filing Documents
- form6-k.htm (6-K) — 23KB
- ex99-1.htm (EX-99.1) — 1370KB
- ex99-2.htm (EX-99.2) — 220KB
- 0001493152-25-017756.txt ( ) — 8467KB
- gnta-20250630.xsd (EX-101.SCH) — 59KB
- gnta-20250630_cal.xml (EX-101.CAL) — 60KB
- gnta-20250630_def.xml (EX-101.DEF) — 255KB
- gnta-20250630_lab.xml (EX-101.LAB) — 425KB
- gnta-20250630_pre.xml (EX-101.PRE) — 354KB
- form6-k_htm.xml (XML) — 1749KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations. 101 The following materials from Genenta's Report on Form 6-K for the six months ended June 30, 2025, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations and Comprehensive Loss, (iii) the Consolidated Statements of Changes in Shareholders' Equity, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to the Consolidated Financial Statements.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENENTA SCIENCE S.P.A. Date: October 10, 2025 By: /s/ Richard B. Slansky Richard B. Slansky, Chief Financial Officer